Roles of ikk kinases and protein kinase ck2 in activation of nuclear factor-κb in breast cancer

Cancer Research

Volumn 61, Issue 9, 2001, Pages 3810-3818

  Romieu Mourez, Raphaëlle ^a   Landesman Bollag, Esther ^a   Seldin, David C ^a   Traish, Abdulmaged M ^a   Mercurio, Frank ^b   Sonenshein, Gail E ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CELGENE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; I KAPPA B; I KAPPA B KINASE; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CASEIN KINASE II; CELL ADHESION; CELL DIVISION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; ENZYME ACTIVATION; HUMANS; I-KAPPA B KINASE; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; TUMOR CELLS, CULTURED;

EID: 0035328531     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Structure, regulation, and function of NF-κB
2. Aberrant Rel/NF-κB genes and activity in human cancer
3. Identification of HTLV-1 tax trans-activator mutants exhibiting novel transcriptional phenotypes
4. Interaction of an NF-κB-like factor with a site upstream of the c-myc promoter
5. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer
6. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth
7. Activation of NF-κB/Rel occurs early during neoplastic transformation of mammary cells
8. Multiple signals converging on NF-κB
9. IKK-γ is an essential regulatory subunit of the 1κB kinase complex
10. Complementation cloning of NEMO, a component of IκB kinase complex essential for NF-κB activation
11. IκB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex
12. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
13. IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation
14. Signal dependent and independent degradation of free and NF-κB bound IκB-α
15. Function and activation of NF-κB in the immune system
16. Constitutive phosphorylation of IκB-α by casein kinase II
17. Phosphorylation of IκB-α in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability
18. Casein kinase II phosphorylates IκB-α at S-283, S-289, S-293, and T-291 and is required for its degradation
19. Constitutive phosphorylation of IκB-α by casein kinase 11 occurs preferentially at serine 293: Requirement for degradation of free IκB-α
20. Protein kinases. 4. Protein kinase CK2: An enzyme with multiple substrates and a puzzling regulation
21. Protein kinase CK2 and its role in cellular proliferation, development, and pathology
22. Novel IκB-α proteolytic pathway in WEHI 231 immature B cells
23. Transformation of human breast epithelial cells by chemical carcinogens
24. Identification and characterization of R-ras 3: A novel member of the RAS gene family with a nonubiquitous pattern of tissue distribution
25. In vitro analysis of Ah receptor domains involved in ligand-activated DNA recognition
26. NF-κB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T-cell stimulation
27. Nuclear Factor-κB/Rel blocks transforming growth factor β1-induced apoptosis of murine hepatocyte cell lines
28. Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box
29. Casein kinase II is a selective target of HIV-1 transcriptional inhibitors
30. The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of the protein kinase CK2
31. Cell cycle-regulated phosphorylation of the human SIX1 homeodomain protein
32. Regulation of NF-κB activity by IκB-related proteins in adenocarcinoma cells
33. bcl-2 overexpression enhances NF-κB activity and induces mmp-9 transcription in human MCF7(ADR) breast-cancer cells
34. Selective activation of NF-κB subunits in human breast cancer
35. Constitutive activation of NF-κB causes resistance to apoptosis in human cutaneous T cell lymphoma HUT-78 cells
36. Constitutive activation of NF-κB in primary adult T-cell leukemia cells
37. The NF-κB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells
38. Transcription factor NF-κB is constitutively activated in acute lymphoblastic leukemia cells
39. Overexpression of IκB α without inhibition of NF-κB activity and mutations in the IκB-α gene in Reed-Sternberg cells
40. Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells
41. Elevated constitutive IκB kinase activity and IκB-α phosphorylation in Hs294T melanoma cells lead to increased basal MGSA/GRO-α transcription
42. Epidermal growth factor-induced nuclear factor-κB activation
43. HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-κB pathway
44. Her-2/neu overexpression induces NF-κB via a P13-kinase/Akt pathway involving calpain-mediated degradation of IκB-α that can be inhibited by the tumor suppressor PTEN
45. Oncogenic Ha-Ras-induced signaling activates NF-κB transcriptional activity, which is required for cellular transformation
46. NF-κB is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis
47. Human T-cell leukemia virus type 1 Tax induction of NF-κB involves activation of IκB kinase α (IKKα) and IKKβ cellular kinases
48. The tax oncoprotein of human T-cell leukemia virus type 1 associates with and persistently activates IκB kinases containing IKKα and IKKβ
49. A-myb rescues murine B-cell lymphomas from IgM-receptor-mediated apoptosis through c-myc transcriptional regulation
50. Association of elevated protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck
51. Protein kinases in human leukemic cells
52. Characterization of casein kinase II in human colonic carcinomas after heterotransplantation into nude mice
53. Casein kinase II is elevated in solid human turnouts and rapidly proliferating non-neoplastic tissue
54. Casein kinase II α transgene-induced murine lymphoma: Relation to theileriosis in cattle
55. Protein kinase CK2 in mammary gland tumorigenesis
56. Transcription factors ets 1, NF-κB, and Sp 1 are major determinants of the promoter activity of the human protein kinase CK2α gene
57. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages
58. Emodin (3-methyl-1, 6, 8-trihydroxyan-thraquinone) inhibits TNF-induced NF-κB activation, IκB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells
59. Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of IκB α in NF-κB activation by an oxidative stress
60. Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression
61. Inhibition of NF-κB/Rel induces apoptosis of murine B cells
62. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1
63. Dual regulation of IL-1β-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-κB and AP-1
64. Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated ReIA